Hemoperfusion Efferon LPS During Cardiac Surgery Using Cardiopulmonary Bypass

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 11, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

January 31, 2026

Conditions
Cardiac DiseaseMultiple Organ Dysfunction Syndrome
Interventions
DEVICE

Efferon LPS

"Efferon LPS, a medical device, which is a single-use cartridge filled with a polymeric adsorbent that selectively adsorbs endotoxin via surface-immobilized ligand and excessive cytokines via its intrinsic porosity.~The hemoperfusion procedure is performed at the time of cardiopulmonary bypass during cardiac surgery. The therapy (Efferon LPS hemoperfusion) is performed once. The duration of the procedure is limited by the time ofcardiopulmonary bypass."

Trial Locations (1)

Unknown

RECRUITING

Pavlov First Saint Petersburg State Medical University, Saint Petersburg

All Listed Sponsors
lead

Efferon JSC

INDUSTRY